| Literature DB >> 35206520 |
Aida Jaffar1,2, Sherina Mohd Sidik1, Chai Nien Foo3, Noor Azimah Muhammad4, Rosliza Abdul Manaf5, Nazhatussima Suhaili6.
Abstract
This pilot randomised control trial (RCT) aimed to evaluate the feasibility and preliminary effectiveness of conducting a full-powered trial for a newly developed pelvic floor muscle training (PFMT) app among pregnant women with urinary incontinence (UI) in Malaysia. This was a prospective, single-centre, single-blind, parallel, randomised controlled, pilot feasibility study-the Kegel Exercise Pregnancy Training app (KEPT app) trial. In total, 26 pregnant women with urinary incontinence from an urban healthcare clinic were recruited and randomly assigned to either intervention or waitlist control group. The intervention group received the KEPT app, while the control group received usual antenatal care (waitlist control). Of the 26 pregnant women, 16 (61.5%) completed the two-month follow-up. The recruitment rate was 54.2%, and the retention rate was 62.5% in the intervention group and 60% in the control group. There was a significant difference between intervention and control groups' baseline measurement in the severity of UI (p = 0.031). The app improved their knowledge (p = 0.011) and self-efficacy (p = 0.038) after the first month and attitude (p = 0.034) after two months of intervention, compared with the control group. This study supports the feasibility of our future cluster RCT. The KEPT app demonstrates a promising effect in improving PFMT attitude and self-efficacy and potentially enhancing exercise adherence among pregnant women with UI. Trial registration: This study was prospectively registered on ClinicalTrials.gov on 19 February 2021 (NCT04762433).Entities:
Keywords: mHealth app; maternal health; mobile application; pelvic floor muscle training; pilot feasibility study; pregnancy; randomised control trial; urinary incontinence
Mesh:
Year: 2022 PMID: 35206520 PMCID: PMC8872112 DOI: 10.3390/ijerph19042332
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Participant inclusion and exclusion criteria.
| Inclusion Criteria | Exclusion Criteria |
|---|---|
| Malaysian citizen | Non-Malaysian citizen |
| Mobile phone (Android) and | Mobile phone (iPhone) |
| Pregnant woman | Planning to be pregnant or post-partum woman |
| Age more than 18 years | Age less than 18 years (Teenage pregnancy) |
| Any parity at 26–27 weeks gestation | Chronic medical problem(s) before pregnancy |
| Stress UI or Mixed UI | Urge UI |
Preliminary effectiveness outcomes.
| Outcome | Description |
|---|---|
| Primary outcome: | |
| PFMT Adherence | Increasing PFMT adherence from lowest score (0) to maximum score (24) of Exercise Adherence Rating Scale (EARS) [ |
| Secondary outcomes: | |
| Urinary incontinence | Severity urinary incontinence symptoms using the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) [ |
| Quality of Life | To assess the quality of life among pregnant women with UI at baseline, one-month, and two-month post-intervention. International Consultation on Incontinence Questionnaire Urinary Incontinence-Lower Urinary Tract Symptom quality of life (ICIQ-LUTSqol) [ |
| PFMT Knowledge, Attitude, and Practice | To assess the knowledge, attitude, and practices towards PFMT at baseline, one-month, and two-month post-intervention. |
| PFMT Self-efficacy | To measure the self-efficacy score at baseline, one-month, and two-month |
PFMT: pelvic floor muscle training.
Baseline characteristics of the intervention vs. control group.
| Characteristics | Overall | Baseline Comparison | Test | ||
|---|---|---|---|---|---|
| Intervention Group | Control Group | ||||
| Age (year), M ± SD | 29.5 ± 4.8 | 29.7 ± 3.9 | 29.1 ± 6.2 |
| 0.772 |
| BMI (kg m2), M ± SD | 28.2 ± 3.9 | 28.7 ± 4.1 | 27.4 ± 3.7 |
| 0.428 |
| Ethnicity, % (n) | |||||
| Malay | 92.3 (24) | 93.8 (15) | 90.0 (9) | ||
| Non-Malay | 7.7 (2) | 6.2 (1) | 10.0 (1) | FET | 1.0 |
| Education, % (n) | |||||
| Primary and Secondary | 30.8 (8) | 31.3 (5) | 30.0 (3) | ||
| College/University | 69.2 (18) | 68.7 (11) | 70.0 (7) | FET | 1.0 |
| Occupational, % (n) | |||||
| Unemployed | 30.8 (8) | 25.0 (4) | 40.0 (4) | ||
| Employed | 69.2 (18) | 75.0 (12) | 60.0 (6) | FET | 0.664 |
| Parity, % (n) | |||||
| Nulliparous | 34.6 (9) | 37.5 (6) | 30.0 (3) | ||
| Multiparous ≥ 1 | 65.4 (17) | 62.5 (10) | 70.0 (7) | FET | 1.0 |
| Type of UI, % (n) | |||||
| SUI | 57.7 (15) | 62.5 (10) | 50.0 (5) | ||
| MUI | 42.3 (11) | 37.5 (6) | 50.0 (5) | FET | 0.689 |
FET: Fisher exact test, t-Test, p < 0.05 significance.
Baseline outcome measures and comparison between intervention and control groups.
| Outcome Measures | Overall | Baseline Comparison | Test | ||
|---|---|---|---|---|---|
| Intervention Group | Control Group | ||||
| UI Severity Score | |||||
| Median (IQR) | 10.00 (5.0) | 7.50 (4.0) | 11.50 (6.0) | MWT | 0.031 * |
| M ± SD | 9.77 ± 5.76 | 7.88 ± 2.34 | 12.80 ± 8.15 | ||
| Quality of life | |||||
| Median (IQR) | 30.50 (12.00) | 29.50 (6.5) | 36.50 (16.75) | MWT | 0.135 |
| M ± SD | 32.85 ± 8.71 | 30.25 ± 5.95 | 37.00 ± 10.97 | ||
| PFMT Knowledge Score | |||||
| Median (IQR) | 7.50 (6.75) | 8.00 (8.25) | 7.50 (6.0) | t | 0.497 |
| M ± SD | 7.62 ±4.46 | 7.125 ± 4.43 | 8.40 ± 4.65 | ||
| PFMT Attitude Score | |||||
| Median (IQR) | 31.00 (5.5) | 31.0 (6.0) | 31.5 (9.25) | MWT | 0.391 |
| M ± SD | 29.01 ± 6.23 | 30.45 ± 5.20 | 30.60 ± 4.97 | ||
| PFMT Practice Score | |||||
| Median (IQR) | 8.00 (5.00) | 8.0 (5.0) | 8.0 (4.5) | MWT | 0.698 |
| M ± SD | 7.77 ± 2.82 | 7.94 ± 3.07 | 7.40 ± 2.50 | ||
| PFMT Self-Efficacy Score | |||||
| Median (IQR) | 53.53 (43.68) | 51.18 (47.94) | 60.88 (42.65) |
| 0.475 |
| M ± SD | 51.47± 26.21 | 48.49 ± 27.51 | 56.24 ± 24.62 | ||
| PFMT Adherence | |||||
| Median (IQR) | 15.00 (4.50) | 14.50 (6.8) | 15.00 (3.00) |
| 0.832 |
| M ± SD | 13.81 ± 4.23 | 13.25 ± 5.12 | 14.70 ± 2.50 | ||
MWT: Mann–Whitney U Test, t-Test, * p < 0.05 significance.
Figure 1CONSORT study flowchart.
The effect of KEPT app on pelvic floor muscle training adherence.
| Outcome Measures | β | SE | 95%CI |
|
|---|---|---|---|---|
| PFMT Adherence | ||||
| Group effect a | 0.442 | 2.4276 | −4.316 to 5.200 | 0.052 |
| Time 2 | 2.369 | 1.0113 | −4.442 to 5.126 | 0.889 |
| Time 3 | 0.033 | 1.0113 | 0.387 to 4.351 | 0.019 * |
| Group*time 2 b | 1.154 | 2.7036 | −4.145 to 6.453 | 0.670 |
| Group*time 3 b | −2.910 | 2.8799 | −8.554 to 2.735 | 0.312 |
Data are presented as β: regression coefficient; SE: standard error; CI: confidence interval; Time 1–3 refer to baseline, 1 month and 2 months post-intervention, respectively. Reference: control group and baseline are the references for group effect and time 1–3, respectively. a Group effect: the difference between groups at 1 month and 2 months post-intervention; Time 2–3: the time effect on control group at 1 month and 2 months post-intervention, respectively, compared with baseline; b Group*time: the difference of the change between two groups at 1 month and 2 months post-intervention, respectively, compared with baseline. * p < 0.05 significance.
Figure 2The mean values and standard errors for PFMT adherence of the two groups across the study.
The effect of KEPT app on PFMT knowledge, attitude, practice, and self-efficacy.
| Outcome Measures | β | SE | 95%CI |
|
|---|---|---|---|---|
| PFMT knowledge | ||||
| Group effect a | −1.343 | 1.6716 | −4.619 to 1.933 | 0.422 |
| Time 2 | −0.473 | 0.6801 | −1.806 to 0.860 | 0.487 |
| Time 3 | 9.218 | 5.5097 | −1.5812 to 0.017 | 0.094 |
| Group*time 2 b | 2.968 | 1.1630 | 0.688 to 5.247 | 0.011 * |
| Group*time 3 b | −3.708 | 5.8277 | −15.130 to 7.714 | 0.525 |
| PFMT attitude | ||||
| Group effect a | −2.642 | 2.2175 | −6.988 to 1.704 | 0.233 |
| Time 2 | −3.552 | 2.8517 | −9.141 to 2.037 | 0.213 |
| Time 3 | −0.309 | 1.9151 | −4.062 to 3.445 | 0.872 |
| Group*time 2 b | 6.246 | 4.0333 | −1.659 to 4.151 | 0.121 |
| Group*time 3 b | 5.884 | 2.7729 | 0.449 to 11.319 | 0.034 * |
| PFMT practice | ||||
| Group effect a | 0.530 | 1.0594 | −1.547 to 2.606 | 0.617 |
| Time 2 | 1.352 | 0.6657 | 0.048 to 2.657 | 0.042 |
| Time 3 | 2.668 | 1.1254 | 0.463 to 4.874 | 0.018 * |
| Group*time 2 b | 0.924 | 1.1624 | −1.355 to 3.202 | 0.427 |
| Group*time 3 b | 0.179 | 1.6070 | −2.971 to 3.329 | 0.911 |
| PFMT Self-efficacy | ||||
| Group effect a | −17.916 | 10.2310 | −37.968 to 2.137 | 0.080 |
| Time 2 | −19.178 | 14.2831 | −47.172 to 8.817 | 0.179 |
| Time 3 | −9.049 | 10.9787 | −30.567 to 12.469 | 0.410 |
| Group*time 2 b | 32.541 | 15.7129 | 1.745 to 63.338 | 0.038 * |
| Group*time 3 b | 16.939 | 14.4040 | −11.293 to 45.170 | 0.240 |
Data are presented as β: regression coefficient; SE: standard error; CI: confidence interval; Time 1–3 refer to baseline, 1 month and 2 months post-intervention, respectively. Reference: control group and baseline are the references for group effect and time 1–3, respectively. a Group effect: the difference between groups at 1 month and 2 months post-intervention; Time 2–3: the time effect on control group at 1 month and 2 months post-intervention, respectively, compared with baseline; b Group*time: the difference of the change between two groups at 1 month and 2 months post-intervention, respectively, compared with baseline. * p < 0.05 significance.
Figure 3The mean values and standard errors for PFMT knowledge, attitude, practice, and self-efficacy of the two groups across this pilot RCT study.
The effect of KEPT app on urinary incontinence and quality of life.
| Outcome Measures | β | SE | 95%CI |
|
|---|---|---|---|---|
| UI Symptom severity | ||||
| Group effect a | −4.989 | 2.4942 | −9.878 to −0.101 | 0.045 * |
| Time 2 | −4.748 | 2.4159 | −9.483 to −0.013 | 0.049 * |
| Time 3 | −5.389 | 3.0569 | −11.380 to 0.603 | 0.078 |
| Group*time 2 b | 4.172 | 2.4941 | −0.717 to 9.060 | 0.094 |
| Group*time 3 b | 3.498 | 3.1421 | −2.661 to 9.656 | 0.266 |
| Quality of Life | ||||
| Group effect a | −7.048 | 3.2752 | −13.467 to −0.628 | 0.031 * |
| Time 2 | 0.000 | 0.0002 | −0.001 to 0.000 | 0.328 |
| Time 3 | −2.000 | 2.2608 | 2.431 to 0.783 | 0.376 |
| Group*time 2 b | 0 | 0.0002 | 0.000 to 0.001 | 0.253 |
| Group*time 3 b | −1.000 | 2.6965 | −6.285 to 4.285 | 0.137 |
Data are presented as β: regression coefficient; SE: standard error; CI: confidence interval; Time 1–3 refer to baseline, 1 month and 2 months post-intervention, respectively. Reference: control group and baseline are the references for group effect and time 1–3, respectively. a Group effect: the difference between groups at 1 month and 2 months post-intervention; Time 2–3: the time effect on control group at 1 month and 2 months post-intervention, respectively, compared with baseline; b Group*time: the difference of the change between two groups at 1 month and 2 months post-intervention, respectively, compared with baseline. * p < 0.05 significance.
Figure 4The mean values and standard errors for urinary incontinence severity and quality of life of the two groups across this pilot RCT study.